Molecular Insight Pharmaceuticals, Inc. Elects a New Board of Directors

News   Feb 29, 2012

 
Molecular Insight Pharmaceuticals, Inc. Elects a New Board of Directors
 
 
 

RELATED ARTICLES

First Multiplex Test for Tick-Borne Diseases

News

A new blood test called the Tick-Borne Disease Serochip (TBD Serochip) promises to revolutionize the diagnosis of tick-borne disease by offering a single test to identify and distinguish between Borrelia burgdorferi, the pathogen responsible for Lyme disease, and seven other tick-borne pathogens.

READ MORE

Insulin Goes Viral: Diabetes and Cancer-causing Mechanisms Explored

News

Every cell in your body responds to the hormone insulin, and if that process starts to fail, you get diabetes. In an unexpected finding, scientists have identified four viruses that can produce insulin-like hormones that are active on human cells. The discovery brings new possibilities for revealing biological mechanisms that may cause diabetes or cancer.

READ MORE

Pre-Clinical Safety in Cancer Drug Development: “Attitude to Safety Needs to Change”

News

Many companies involved in cancer drug research and development need to re-think their use of safety data in helping to bring new drugs to cancer patients.

Dr Richard Knight of ApconiX will tell this month’s conference, that greater focus on pre-clinical safety should be fundamental to the development of new cancer therapies.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE